New insights into anti-HER-2 receptor monoclonal antibody research

Seminars in Oncology

Volumn 27, Issue 6 SUPPL. 11, 2000, Pages 84-91

  Kumar, R ^a   Mandal, M ^a   Vadlamudi, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RIBOZYME; TRANSCRIPTION FACTOR; TRASTUZUMAB;

AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOLOGY; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; COLON CANCER; CONFERENCE PAPER; GENE AMPLIFICATION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; ONCOGENE C ERB; ONCOGENE NEU; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; GENES, ERBB-2; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 0034473365     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Signal transduction by receptors with tyrosine kinase activity
2. The biology of the erbB-2/neu/ HER-2 and its role in cancer
3. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
4. Diversification of neu differentiation factor and epidermal growth factor signaling by combinational receptor interactions
5. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
6. Ligand activation of overexpressed epidermal growth factor receptors transform NIH 3T3 mouse fibroblasts
7. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2
8. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3
9. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations
10. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling
11. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity
12. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody
13. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly
14. Her2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor
15. Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells
16. Efficacy and safety of Herceptin (humanized anti-HER2 antibody) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherapy for metastatic breast cancer
17. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53
18. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast cancer carcinoma cells that overexpress HER2/neu
19. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein
20. Tyrosine kinase inhibitors, emodin and its derivative repress HER2/neu-induced cellular transformation and metastasis-associated properties
21. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated With inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells
22. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene
23. Differential expression of epidermal growth factor-related proteins in human colorectal tumors
24. In vivo overexpression of c-erbB-2 oncoprotein in xenografts of mice implanted with human colon cancer lines
25. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer
26. Prostaglandin H synthetase Z is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
27. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
28. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
29. Regulation of cyclooxygenase-2 pathway by HER2 receptor
30. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts
31. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis
32. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin
33. Nuclear targeting of Bax during apoptosis in human colorectal cancer cells
34. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
35. Epidermal growth factor receptor and other oncogenes as prognostic markers
36. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland
37. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase
38. Transcriptional upregulation of paxillin expression by heregulin in human breast cancer cells
39. Serine modification of paxillin by heregulin: Role of p38 mitogen-activated protein kinase